Alzheimer’s disease: treatments at last

On the 6th of January 2023 the Food and Drug Administration (FDA) approved Lecanemab-irmb through the accelerated approval pathway to treat Alzheimer’s disease. There has been rigorous efforts to combat this dreaded disease. Lecanemab is a second drug now approved for the treatment of Alzheimer’s disease. The first, named aducanumab, was earlier approved by FDAContinue reading “Alzheimer’s disease: treatments at last”

The heart can become 10 years younger with anti-aging gene therapy

Longevity gene/protein has been shown to reverse the biological age of the heart by 10 years. The ground breaking research was a product of several years of research by scientists at the University of Bristol and the Multimedica group in Italy. Carriers of healthy mutant genes most times live up to 100 or more yearsContinue reading “The heart can become 10 years younger with anti-aging gene therapy”